TB-500 10 mg

Price: Original price was: CHF 89.00.Current price is: CHF 66.00.

Associated with Thymosin Beta-4, a naturally occurring peptide involved in tissue repair, wound healing and cellular regeneration. Research explores its role in cell migration, blood vessel formation (angiogenesis), inflammatory regulation and tissue remodeling, including recovery in muscle, tendon, skin and cardiovascular tissue.

Title
4 vials (15% discount)
8 vials (25% discount)
12 vials (35% disocunt)

Description

Overview

TB-500 is a synthetic peptide associated with research into Thymosin Beta-4 (TB4), a naturally occurring protein consisting of 43 amino acids. Thymosin Beta-4 plays an important role in actin regulation, cellular migration and biological processes involved in tissue maintenance and repair.

Thymosin Beta-4 has been investigated in laboratory and preclinical research examining wound healing, inflammatory regulation, angiogenesis and tissue regeneration. Its biological activity is closely associated with its ability to bind actin, a structural protein involved in maintaining cellular architecture and supporting cell movement.

Experimental studies have explored the involvement of Thymosin Beta-4 in epithelial cell migration, fibroblast activity and extracellular matrix remodeling. These processes are relevant to understanding tissue repair and cellular responses following injury.

Additional research has examined Thymosin Beta-4 in experimental models involving skeletal muscle, cardiac tissue and inflammatory conditions. Certain pharmaceutical formulations of Thymosin Beta-4 have also undergone human clinical investigation, particularly in ophthalmic research.

TB-500 / TB4 10 mg is presented as an experimental research peptide for laboratory and scientific applications. The stated quantity refers to the amount of peptide contained in the product and should not be interpreted as a recommended human dosage.

Key Information

  • Product: TB-500 / TB4

  • Strength: 10 mg

  • Related compound: Thymosin Beta-4

  • Category: Recovery

  • Compound classification: Synthetic research peptide associated with Thymosin Beta-4

  • Research target: Actin-associated cellular processes, cell migration and tissue repair signaling

  • Research focus: Tissue repair, wound healing, cellular migration, angiogenesis, inflammatory regulation and extracellular matrix remodeling

  • Mechanism: Thymosin Beta-4 binds actin and participates in cytoskeletal regulation and cellular migration.

  • Intended use: Laboratory and research use only

Related Products

WOLVERINE is a multi-peptide research formulation of BPC-157 and TB-500. These peptides are individually investigated for their involvement in tissue repair, cellular migration, inflammatory signaling and extracellular matrix remodeling.

A tripeptide corresponding to the C-terminal sequence Lys-Pro-Val associated with ฮฑ-MSH biology. Research interest centres on cellular signalling involved in inflammatory and immune-regulatory processes.

A combined formulation intended for studying multiple signalling components within one experimental system, BPC-157 + TB-500 + GHK-Cu + KPV blend.

A multi-component research formulation combining peptides associated with cellular repair, extracellular-matrix signalling and tissue-remodelling research. The final page should identify every component and its exact amount rather than marketing GLOW as a single molecular entity.

A synthetic 15-amino-acid peptide extensively investigated in preclinical models involving cellular protection, vascular signalling and tissue-repair biology. Despite considerable experimental interest, human clinical evidence remains limited and no approved therapeutic formulation exists.

A synthetic peptide derived from the helix-B region of erythropoietin (EPO), investigated for tissue-protective signalling without reproducing EPOโ€™s erythropoietic activity. Its research landscape includes inflammatory regulation, cellular protection and tissue-repair signalling pathways.